Akebia Therapeutics' Vafseo expansion may boost future growth despite Auryxia's exclusivity loss. Read why AKBA stock is ...

Stride boasts strong financials, with a 14% revenue CAGR and a 33% adjusted operating income CAGR over the past two years.

CEFs can offer opportunities to invest in assets at below their current valuation. Check out two CEFs that have a long ...

MercadoLibre remains Latin America's dominant e-commerce and fintech leader, with robust growth across all business lines.

Best Buy faces flat sales growth and retail challenges amidst weak consumer spending. Read why I recommend staying on the ...

Wall Street's major averages on Friday took home gains, with the S&P 500 reclaiming the 6,000 level for the first time since ...

Asking rents fell Y/Y in May in a majority of major U.S. metro areas -- the most in two years -- as demand struggled to keep ...

Meta is set to test all-time highs with upside from Reality Labs, store expansion, and VR content deals. Check out why META ...

"Chinese Vice Premier He Lifeng will visit the UK from June 8 to 13. While in the UK, he will hold the first meeting of the ...

UYLD is a low-volatility ETF with a 5.2% SEC yield, investment-grade assets, and strong performance. Read why UYLD is ideal ...

Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...

Palantir sees growth with a Rule of 40 score of 83 and raised guidance by $150M. Read more on why I think it's more of a Hold ...